(RTTNews) - Repligen Corp. (RGEN), a bioprocessing company, on Friday announced agreements to issue $1 billion in 0.25% convertible senior notes due 2031.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.